Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X0FU
|
|||
| Former ID |
DNCL002994
|
|||
| Drug Name |
KP-1461
|
|||
| Synonyms |
KP1461; 943540-08-7; C522536000
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62] | Phase 2 | [1] | |
| Pneumococcal infection [ICD-11: CA00-CA40] | Phase 2 | [1] | ||
| Company |
Koronis Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H28N4O6
|
|||
| Canonical SMILES |
CCCCCCCOC(=O)NC1=NCN(C(=O)N1)C2CC(C(O2)CO)O
|
|||
| InChI |
1S/C16H28N4O6/c1-2-3-4-5-6-7-25-16(24)19-14-17-10-20(15(23)18-14)13-8-11(22)12(9-21)26-13/h11-13,21-22H,2-10H2,1H3,(H2,17,18,19,23,24)/t11-,12+,13+/m0/s1
|
|||
| InChIKey |
SZWIAFVYPPMZML-YNEHKIRRSA-N
|
|||
| CAS Number |
CAS 815588-85-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00504452) Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.